Allogene Therapeutics, Inc. · NASDAQ:ALLO
Allogene Therapeutics, Inc. shareholders
As of Jun 30, 2026, 204 institutions reported holding Allogene Therapeutics, Inc., 90.5% of its shares. Largest: BlackRock, Frazier Life Sciences Management, L.P. and Pfizer Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Allogene Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 30.1M | 8.7% | +11.1M | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | 22.4M | 6.5% | +18.6M | Aug 14, 2026 |
| Pfizer Inc | 22M | 6.4% | no change | Aug 13, 2026 |
| State Street | 19M | 5.5% | +10.4M | Aug 7, 2026 |
| Tpg Gp A, LLC | 18.7M | 5.4% | no change | Aug 14, 2026 |
| Vanguard | 18.5M | 5.4% | +8.6M | Aug 13, 2026 |
| Sio Capital Management, LLC | 13.3M | 3.9% | new | Aug 14, 2026 |
| Primecap Management Co | 13.1M | 3.8% | +4.74M | Aug 14, 2026 |
| Fidelity | 12M | 3.5% | +10.4M | Aug 13, 2026 |
| Citadel | 10.1M | 2.9% | +3.29M | Aug 14, 2026 |